MERCK 049 for newly diagnosed Type II diabetics who are drug naïve and for whom diet/exercise regimen are not effective. This is a 4 month trial.
If you think you may be a candidate for any of these trials, contact Michelle Wells, CSHP Clinical Research Coordinator, at (719) 866-6633.